98
Views
2
CrossRef citations to date
0
Altmetric
Lens

Evaluation of the Putative Efficacy of a Methanolic Extract of Ocimum Basilicum in Preventing Disruption of Structural Proteins in an in Vitro System of Selenite-induced Cataractogenesis

, , , &
Pages 696-704 | Received 03 Sep 2019, Accepted 21 Nov 2019, Published online: 06 Dec 2019

References

  • Flaxman SR, Bourne RRA, Resnikoff S, Ackland P, Braithwaite T, Cicinelli MV, Das A, Jonas JB, Keeffe J, Kempen JH, et al. Vision loss expert group of the global burden of disease study. Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis. Lancet Glob Health. 2017;5(12):e1221–e1234. doi:10.1016/S2214-109X(17)30393-5.
  • Kahn HA, Leibowitz HM, Ganley JP, Kini MM, Colton T, Nickerson RS, Dawber TR. The framingham eye study. I. Outline and major prevalence findings. Am J Epidemiol. 1977;106(1):17–32. doi:10.1093/oxfordjournals.aje.a112428.
  • Garner MH, Spector A. Sulfur oxidation in selected human cortical cataracts and nuclear cataracts. Exp Eye Res. 1980;31(3):361–69. doi:10.1016/s0014-4835(80)80044-3.
  • Lou MF, Dickerson JE Jr, Garadi R. The role of protein-thiol mixed disulfides in cataractogenesis. Exp Eye Res. 1990;50(6):819–26. doi:10.1016/0014-4835(90)90133-f.
  • Truscott RJ, Augusteyn RC. Changes in human lens proteins during nuclear cataract formation. Exp Eye Res. 1977;24(2):159–70. doi:10.1016/0014-4835(77)90256-1.
  • Sakthivel M, Geraldine P, Thomas PA. Alterations in the lenticular protein profile in experimental selenite-induced cataractogenesis and prevention by ellagic acid. Graefes Arch Clin Exp Ophthalmol. 2011;249(8):1201–10. doi:10.1007/s00417-011-1644-6.
  • Higashi Y, Higashi K, Mori A, Sakamoto K, Ishii K, Nakahara T. Anti-cataract effect of resveratrol in high-glucose-treated streptozotocin-induced diabetic rats. Biol Pharm Bull. 2018;41(10):1586–92. doi:10.1248/bpb.b18-00328.
  • Bahmani F, Bathaie SZ, Aldavood SJ, Ghahghaei A. Prevention of α-crystallin glycation and aggregation using l-lysine results in the inhibition of in vitro catalase heat-induced-aggregation and suppression of cataract formation in the diabetic rat. Int J Biol Macromol. 2019;132:1200–07. doi:10.1016/j.ijbiomac.2019.04.037.
  • Gupta SK, Srivastava S, Trivedi D, Joshi S, Halder N. Ocimum sanctum modulates selenite-induced cataractogenic changes and prevents rat lens opacification. Curr Eye Res. 2005;30(7):583–91. doi:10.1080/02713680590968132.
  • Kyei S, Koffuor GA, Ramkissoon P, Afari C, Asiamah EA. The claim of anti-cataract potential of heliotropium indicum: a myth or reality? Ophthalmol Ther. 2015;4(2):115–28. doi:10.1007/s40123-015-0042-2.
  • Kavoosi G, Amirghofran Z. Chemical composition, radical scavenging and anti-oxidant capacity of Ocimum basilicum essential oil. J Essential Oil Res. 2016;29(2):189–99. doi:10.1080/10412905.2016.1213667.
  • Anand T, Sundararajan M, Anbukkarasi M, Thomas PA, Geraldine P. A methanolic extract of Ocimum basilicum exhibits antioxidant effects and prevents selenite-induced cataract formation in cultured lenses of Wistar rats. Pharmacogn J. 2019;11(3):496–504. doi:10.5530/pj.2019.11.79.
  • Marian MJ, Li H, Borchman D, Paterson CA. Plasma membrane Ca2+-ATPase expression in the human lens. Exp Eye Res. 2005;81(1):57–64. doi:10.1016/j.exer.2005.01.011.
  • Kadan S, Saad B, Sasson Y, Zaid H. In vitro evaluation of anti-diabetic activity and cytotoxicity of chemically analysed Ocimum basilicum extracts. Food Chem. 2016;196:1066–74. doi:10.1016/j.foodchem.2015.10.044.
  • Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–54. doi:10.1006/abio.1976.9999.
  • Altomare E, Grattagliano I, Vendemaile G, Micelli-Ferrari T, Signorile A, Cardia L. Oxidative protein damage in human diabetic eye: evidence of a retinal participation. Eur J Clin Invest. 1997;27(2):141–47. doi:10.1046/j.1365-2362.1997.780629.x.
  • Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S, Stadtman ER. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 1990;186:464–78. doi:10.1016/0076-6879(90)86141-h.
  • Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227(5259):680–85. doi:10.1038/227680a0.
  • Braakhuis AJ, Donaldson CI, Lim JC, Donaldson PJ. Nutritional strategies to prevent lens cataract: current status and future strategies. Nutrients. 2019;11(5):1186. doi:10.3390/nu11051186.
  • Rautiainen S, Lindblad BE, Morgenstern R, Wolk A. Total antioxidant capacity of the diet and risk of age-related cataract: a population-based prospective cohort of women. JAMA Ophthalmol. 2014;132(3):247–52. doi:10.1001/jamaophthalmol.2013.6241.
  • Boggia R, Zunin P, Hysenaj V, Bottino A, Comite A Dehydration of basil leaves and impact of processing composition. In Processing and Impact on Active Components in Food; 2015 Jan 1 p. 645–53. Academic Press. Doi: 10.1016/B978-0-12-404699-3.00078-0.
  • Dzoyem JP, McGaw LJ, Kuete V, Bakowsky U Anti-inflammatory and anti-nociceptive activities of African medicinal spices and vegetables. In Medicinal Spices and Vegetables from Africa; 2017 p. 239–70. Academic Press. Doi: 10.1016/B978-0-12-809286-6.00009-1.
  • Clark JI. Development and maintenance of lens transparency. In: Albert DM and Jakobiec FA, editors. Principles and practice of ophthalmology. Philadelphia (PA): W. B. Saunders Company; 1994. p. 114–23.
  • Shearer TR, Ma H, Fukiage C, Azuma M. Selenite nuclear cataract: review of the model. Mol Vis. 1997;3:8.
  • Ahuja RP, Borchman D, Dean WL, Paterson CA, Zeng J, Zhang Z, Ferguson-Yankey S, Yappert MC. Effect of oxidation on Ca2+ -ATPase activity and membrane lipids in lens epithelial microsomes. Free Radic Biol Med. 1999;27(1–2):177–85. doi:10.1016/s0891-5849(99)00068-4.
  • Borchman D, Paterson CA, Delamere NA. Oxidative inhibition of Ca2+-ATPase in the rabbit lens. Invest Ophthalmol Vis Sci. 1989;30:1633–37.
  • Pescosolido N, Barbato A, Giannotti R, Komaiha C, Lenarduzzi F. Age-related changes in the kinetics of human lenses: prevention of the cataract. Int J Ophthalmol. 2016;9(10):1506–17. doi:10.18240/ijo.2016.10.23.
  • Herczenik E, Gebbink MF. Molecular and cellular aspects of protein misfolding and disease. Faseb J. 2008;22(7):2115–33. doi:10.1096/fj.07-099671.
  • Takata T, Oxford JT, Demeler B, Lampi KJ. Deamidation destabilizes and triggers aggregation of a lens protein, betaA3-crystallin. Protein Sci. 2008;17(9):1565–75. doi:10.1110/ps.035410.108.
  • Zhang K, Zhu X, Lu Y. The proteome of cataract markers: focus on crystallins. Adv Clin Chem. 2018;86:179–210. doi:10.1016/bs.acc.2018.05.005.
  • Benedek GB. Theory of transparency of the eye. Appl Opt. 1971;10(3):459–73. doi:10.1364/AO.10.000459.
  • Mathew N, Kalyanasundaram M, Balaraman K. Glutathione S-transferase (GST) inhibitors. Expert Opin Ther Pat. 2006;16(4):431–44. doi:10.1517/13543776.16.4.431.
  • Rooban BN, Lija Y, Biju PG, Sasikala V, Sahasranamam V, Abraham A. Vitex negundo attenuates calpain activation and cataractogenesis in selenite models. Exp Eye Res. 2009;88(3):575–82. doi:10.1016/j.exer.2008.11.020.
  • Makri OE, Ferlemi AV, Lamari FN, Georgakopoulos CD. Saffron administration prevents selenite-induced cataractogenesis. Mol Vis. 2013;19:1188–97.
  • Ferlemi AV, Makri OE, Mermigki PG, Lamari FN, Georgakopoulos CD. Quercetin glycosides and chlorogenic acid in highbush blueberry leaf decoction prevent cataractogenesis in vivo and in vitro: investigation of the effect on calpains, antioxidant and metal chelating properties. Exp Eye Res. 2016;145:258–68. doi:10.1016/j.exer.2016.01.012.
  • Aydin B, Yagci R, Yilmaz FM, Erdurmus M, Karadağ R, Keskin U, Durmus M, Yigitoglu R. Prevention of selenite-induced cataractogenesis by N-acetylcysteine in rats. Curr Eye Res. 2009;34(3):196–201. doi:10.1080/02713680802676885.
  • Xia JZ, Wang Q, Tatarkova S, Aerts T, Clauwaert J. Structural basis of eye lens transparency: light scattering by concentrated solutions of bovine alpha-crystallin proteins. Biophys J. 1996;71(5):2815–22. doi:10.1016/S0006-3495(96)79477-8.
  • Clark JI, Matsushima H, David LL, Clark JM. Lens cytoskeleton and transparency: a model. Eye (Lond). 1999;13(Pt3b):417–24. doi:10.1038/eye.1999.116.
  • Kim J, Choung SY. Pinus densiflora bark extract prevents selenite-induced cataract formation in the lens of sprague dawley rat pups. Mol Vis. 2017;23:638–48.
  • Horwitz J, Bova MP, Ding LL, Haley DA, Stewart PL. Lens α-crystallin: function and structure. Eye. 1999;13(3b):403. doi:10.1038/eye.1999.114.
  • Hanson SR, Hasan A, Smith DL, Smith JB. The major in vivo modifications of the human water-insoluble lens crystallins are disulfide bonds, deamidation, methionine oxidation and backbone cleavage. Exp Eye Res. 2000;71(2):195–207. doi:10.1006/exer.2000.0868.
  • Nakazawa Y, Oka M, Tamura H, Takehana M. Effect of hesperetin on chaperone activity in selenite-induced cataract. Open Med (Wars). 2016;11(1):183–89. doi:10.1515/med-2016-0035.
  • Bai J, Zheng Y, Wang G, Liu P. Protective effect of D-limonene against oxidative stress-induced cell damage in human lens epithelial cells via the p38 pathway. Oxid Med Cell Longev. 2016;2016:5962832. doi:10.1155/2016/5962832.
  • David LL, Shearer TR. β‐Crystallins insolubilized by calpain II in vitro contain cleavage sites similar to β‐crystallins insolubilized during cataract. FEBS Lett. 1993;324(3):265–70. doi:10.1016/0014-5793(93)80131-D.
  • Biswas S, Harris F, Dennison S, Singh J, Phoenix DA. Calpains: targets of cataract prevention? Trends Mol Med. 2004 Feb 1;10(2):78–84. doi:10.1016/j.molmed.2003.12.007.
  • Kumari RP, Ramkumar S, Thankappan B, Natarajaseenivasan K, Balaji S, Anbarasu K. Transcriptional regulation of crystallin, redox, and apoptotic genes by C-Phycocyanin in the selenite-induced cataractogenic rat model. Mol Vis. 2015;21:26–39.
  • Sundararajan M, Thomas PA, Babyshalini K, Geraldine P. Identification of phytoconstituents and in-vitro evaluation of the putative anticataractogenic effect of an ethanolic root extract of Leucas aspera. Biomed Pharmacother. 2017;85:87–101. doi:10.1016/j.biopha.2016.11.126.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.